Form 4 for RVMD Revolution Medicines, Inc.
Accepted 2021-09-21 00:00:00 ET · period of report 2021-09-17 · accession 0001567619-21-017415 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-09-21 | 2021-09-17 | RVMD | Wang Xiaolin | See Remarks | S - Sale | $30.02 | -250 | 12.2K | -2% | -$7,505 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-17 | S | D | 250 | $30.02 | 12,195 | D | — | — | (F2) Includes 9,800 RSUs. |